{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:59:53Z","timestamp":1776743993716,"version":"3.51.2"},"reference-count":39,"publisher":"Media Sphere Publishing House","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>Objective. To determine the significance of immunological markers in patients with obstructive sleep apnea (OSA) and comorbid pathology. Material and methods. Sixty-five patients were examined. Two groups of patients were distinguished: the main group with moderate and severe OSA and the control group without OSA. The subjects underwent anthropometry, polysomnography, assessment of cognitive and emotional disorders. Glial fibrillar acidic protein (GFAP), antibodies against NR1-NR2 subunits of NMDA receptors (AT to GRIN2A) and the acetylcholine receptor (AT to AChR), and brain-derived neurotrophic factor (BDNF) were studied by enzyme immunoassay. Results. In patients with OSA, indicators of markers: GFAP (p=0.017), BDNF (p=0.006), antibodies to AChR (p=0.002), as well as chronic cerebral ischemia (p=0.000), depression on the HADS (p=0.004) and the Beck scale (p=0.000), drowsiness on the Epworth scale (p=0.001), asthenia on the visual analogue scale (p=0.000) and the MFI 20 (p=0.013) were higher than in the control group. A relationship was established in the main group between the identified subjective disorders on the Mini-Mental State Examination scale (MMSE) and BDNF (r=0.302, p=0.014) and the average score on the MMSE and BDNF (r=\u20130.266, p=0.032). Conclusion. The results demonstrate the relationship of neurospecific proteins with cognitive impairment in patients with OSA. The neuromarker GFAP in patients with sleep apnea has shown itself to be a predictor of decreased neurogenesis, and BDNF as a representative marker of neuroplasticity. Large values of AT to AChR in patients with OSA may indicate possible neuromuscular transmission disorders. Along with drowsiness and asthenia, patients with OSA have changes in the emotional background, mainly due to depression. The severity of depression and the severity of asthenia increase with increasing severity of apnea and are probably associated with low levels of saturation, which in turn leads to dysregulation of the prefrontal cortex, hippocampus and amygdala.<\/jats:p>","DOI":"10.17116\/jnevro202412408147","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T13:58:22Z","timestamp":1726235902000},"page":"47","source":"Crossref","is-referenced-by-count":1,"title":["Significance of immunological markers in patients with obstructive sleep apnea and comorbid pathology"],"prefix":"10.17116","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3804-6998","authenticated-orcid":false,"given":"S.S.","family":"Rubina","sequence":"first","affiliation":[{"name":"Tver State Medical University","place":["Tver, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-4866","authenticated-orcid":false,"given":"L.V.","family":"Chichanovskaya","sequence":"additional","affiliation":[{"name":"Tver State Medical University","place":["Tver, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-3389","authenticated-orcid":false,"given":"I.I.","family":"Makarova","sequence":"additional","affiliation":[{"name":"Tver State Medical University","place":["Tver, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.N.","family":"Slusar","sequence":"additional","affiliation":[{"name":"Tver State Medical University","place":["Tver, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202412408147-1","doi-asserted-by":"crossref","unstructured":"Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Am Rev Med. 1976;27:465-484","DOI":"10.1146\/annurev.me.27.020176.002341"},{"key":"key-10.17116\/jnevro202412408147-2","doi-asserted-by":"crossref","unstructured":"Tishkevich ES, Kolyadich ZhV. Risk factors for obstructive sleep apnea syndrome. Otorinolaringologiya. Vostochnaya Evropa. 2020;10(2):96-102. (In Russ.)","DOI":"10.34883\/PI.2020.2.2.001"},{"key":"key-10.17116\/jnevro202412408147-3","doi-asserted-by":"publisher","DOI":"10.20996\/1819-6446-2021-08-05"},{"key":"key-10.17116\/jnevro202412408147-4","doi-asserted-by":"publisher","DOI":"10.52420\/2071-5943-2021-20-4-85-92"},{"key":"key-10.17116\/jnevro202412408147-5","unstructured":"Yashchenko AV, Kamaev YuO. The risk of developing cognitive impairment in patients with obstructive sleep apnea syndrome. Vestnik Psikhofiziologii. 2018;(3):128-132. (In Russ.)"},{"key":"key-10.17116\/jnevro202412408147-6","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202012001190"},{"key":"key-10.17116\/jnevro202412408147-7","doi-asserted-by":"crossref","unstructured":"DeZee KJ, Hatzigeorgiou C, Kristo D, et al. Prevalence of and screening for mental disorders in a sleep clinic. J Clin Sleep Med. 2005;1(2):136-142","DOI":"10.5664\/jcsm.26307"},{"key":"key-10.17116\/jnevro202412408147-8","doi-asserted-by":"publisher","DOI":"10.33029\/9704-5717-7-APN-2020-1-112"},{"key":"key-10.17116\/jnevro202412408147-9","unstructured":"Rubina SS, Makarova II, Ignatova YuP, et al. Features of heart rate variability in patients with obstructive sleep apnea and comorbid pathology in neurological practice. Ural\u2019skii Meditsinskii Zhurnal. 2022;21(4):4-12. (In Russ.)"},{"key":"key-10.17116\/jnevro202412408147-10","doi-asserted-by":"crossref","unstructured":"Bianchi R, Garbuglia M, Verzini M, et al. S100 protein and annexin II2- pl12 (calpactin I) act in concert to regulate the state of assembly of GFAP intermediate filaments in vitro. Biochem. Biophys. Res. Commun. 1995;208(3):910-918","DOI":"10.1006\/bbrc.1995.1421"},{"key":"key-10.17116\/jnevro202412408147-11","doi-asserted-by":"crossref","unstructured":"Brenner M. Structure and transcriptional regulation of GFAP gene. Brain Pathol. 1994;4:245-257","DOI":"10.1111\/j.1750-3639.1994.tb00840.x"},{"key":"key-10.17116\/jnevro202412408147-12","doi-asserted-by":"crossref","unstructured":"Pavlov KA, Gurina OI, Dmitrieva TB, et al. Development of a GFAP enzyme immunoassay based on a recombinant antigen. Byul. Eksperim. Biologii i Meditsiny. 2008;146(11):535-540. (In Russ.)","DOI":"10.1007\/s10517-009-0347-z"},{"key":"key-10.17116\/jnevro202412408147-13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59660"},{"key":"key-10.17116\/jnevro202412408147-14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.3671"},{"key":"key-10.17116\/jnevro202412408147-15","unstructured":"Krasnov AV. Astrocyte proteins of the brain: structure, functions, clinical significance. Neironauka i Klinicheskaya Nevrologiya. 2012;17(1):37-42. (In Russ.)"},{"key":"key-10.17116\/jnevro202412408147-16","unstructured":"Chekhonin VP, Dmitrieva TB, Zhirkov YuA. Immunokhimicheskii analiz neirospetsificheskikh antigenov. M. 2000. (In Russ.)"},{"key":"key-10.17116\/jnevro202412408147-17","doi-asserted-by":"publisher","DOI":"10.2174\/13894501113149990156"},{"key":"key-10.17116\/jnevro202412408147-18","doi-asserted-by":"publisher","DOI":"10.31857\/S0044467721040079"},{"key":"key-10.17116\/jnevro202412408147-19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00486"},{"key":"key-10.17116\/jnevro202412408147-20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227834"},{"key":"key-10.17116\/jnevro202412408147-21","doi-asserted-by":"publisher","DOI":"10.29296\/24999490-2021-03-02"},{"key":"key-10.17116\/jnevro202412408147-22","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-019-01007-y"},{"key":"key-10.17116\/jnevro202412408147-23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2020.12.004"},{"key":"key-10.17116\/jnevro202412408147-24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21050"},{"key":"key-10.17116\/jnevro202412408147-25","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160763"},{"key":"key-10.17116\/jnevro202412408147-26","doi-asserted-by":"crossref","unstructured":"Wenke NK, Kreye J, Andrzejak E, et al. N-methyl-D-aspartate receptor dysfunction by unmutated human antibodies against the NR1 subunit. Annals of Neurology. 2019;85(5):771-776","DOI":"10.1002\/ana.25460"},{"key":"key-10.17116\/jnevro202412408147-27","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90204-j"},{"key":"key-10.17116\/jnevro202412408147-28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.05.005"},{"key":"key-10.17116\/jnevro202412408147-29","unstructured":"Sanadze AG. Miasteniya i miastenicheskie sindromy. M.: Litera; 2012. (In Russ.)"},{"key":"key-10.17116\/jnevro202412408147-30","unstructured":"Makarina-Kibak LE, Kolyadich ZhV, Zatoloka DA, et al. Results of the soft palate implantation method for the treatment of snoring and obstructive sleep apnea syndrome. Otorinolaringologiya. Vostochnaya Evropa. 2012;2(07):91-98. (In Russ.)"},{"key":"key-10.17116\/jnevro202412408147-31","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2021-1-4-12"},{"key":"key-10.17116\/jnevro202412408147-32","doi-asserted-by":"crossref","unstructured":"Epstein LJ, Kristo D, Strollo PJJr, et al. Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263-276","DOI":"10.5664\/jcsm.27497"},{"key":"key-10.17116\/jnevro202412408147-33","doi-asserted-by":"crossref","unstructured":"American Academy of Sleep Medicine Task Force. Sleeprelated breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22(5):667-689","DOI":"10.1093\/sleep\/22.5.667"},{"key":"key-10.17116\/jnevro202412408147-34","unstructured":"Zakharov VV, Voznesenskaya TG. Nervno-psikhicheskie narusheniya: diagnosticheskie testy. 2-e izd. M.: MEDpress-inform; 2013. (In Russ.)"},{"key":"key-10.17116\/jnevro202412408147-35","doi-asserted-by":"crossref","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540-545","DOI":"10.1093\/sleep\/14.6.540"},{"key":"key-10.17116\/jnevro202412408147-36","doi-asserted-by":"crossref","unstructured":"Smets EM, Garssen B, Bonke B, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39(3):315-325","DOI":"10.1016\/0022-3999(94)00125-O"},{"key":"key-10.17116\/jnevro202412408147-37","unstructured":"Piotrowski C. Co-Morbidity of Sleep Disorders in Veterans with PTSD: An Integrated Synopsis of 109 Studies (1995-2020). SIS Journal of Projective Psychology & Mental Health. 2020;27(2):83-97"},{"key":"key-10.17116\/jnevro202412408147-38","unstructured":"Semchenko VV, Stepanov SS, Bogolepov NN. Sinapticheskaya plastichnost\u2019 golovnogo mozga (fundamental\u2019nye i prikladnye aspekty). Omsk, Omsk Regional Printing House; 2008. (In Russ.)"},{"key":"key-10.17116\/jnevro202412408147-39","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00032-2018"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:03:34Z","timestamp":1745384614000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2024\/8\/1199772982024081047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,9,13]]}},"alternative-id":["10.17116\/jnevro202412408147"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202412408147","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}